Prelude Therapeutics PRLD
NASDAQ PRLD
$3.66 +0.13 (+3.82%)
As of: Oct 21, 2026 · 11:39 AM EDT

Prelude Therapeutics (PRLD) Operating Margin (2024 - 2026)

Updated

Prelude Therapeutics (PRLD) recorded Operating Margin of -270.93% in Q2 2026, up 38.61 percentage points from the prior quarter.

Analysis

Prelude Therapeutics (PRLD) Operating Margin (2024 - 2026) Analysis & Trends

On a TTM basis, Prelude Therapeutics' Operating Margin came in at -300.56% as of Jun 30, 2026, up 1628.11 percentage points year-over-year; for FY2025, it came in at -861.33%, up 1134.58 percentage points from FY2024.

  • Across earlier years, Operating Margin came in at -1995.91% in FY2024.
  • Per Business Quant, the preceding three quarters came in at -309.54% (Q1 2026), -307.59% (Q4 2025) and -314.12% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin (Qtr)
1 Eli Lilly 1,130.22 Bn 1,098.81 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 613.62 Bn 532.15 Bn 17.26 Bn 28.21%
3 AbbVie 501.46 Bn 474.57 Bn 12.70 Bn 37.86%
4 Merck 366.84 Bn 321.22 Bn 12.21 Bn -3.52%
5 Novartis Ag 297.85 Bn 261.84 Bn 11.24 Bn 32.97%
6 Astrazeneca 261.66 Bn 235.34 Bn 12.86 Bn 20.57%
7 Amgen 235.39 Bn 190.79 Bn 7.24 Bn 34.95%
8 Gilead Sciences 190.66 Bn 164.86 Bn 6.22 Bn -133.21%
9 Pfizer 169.57 Bn 116.22 Bn 10.94 Bn 28.37%
10 Prelude Therapeutics 360.10 Mn -237.20 Mn - -270.93%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -270.93%
Mar 31, 2026 -309.54%
Dec 31, 2025 -307.59%
Sep 30, 2025 -314.12%
Dec 31, 2024 -845.78%
Sep 30, 2024 -1,145.87%
API Access

Prelude Therapeutics Operating Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-margin&ticker=PRLD&period=max&api_key=YOUR_API_KEY